SP5 and liver cancer: Characterization of liver cancer pathways in tumor samples: We generated cell lines from HBL, HCC, HCN-NOS, and lung metastases patient tumors, which were resistant to cisplatin treatments and demonstrated elevated HDAC1 and Sp5 proteins.